標題: Titlebook: Drug Discovery and Drug Development; The Indian Narrative Madhu Dikshit Book 2021 Springer Nature Singapore Pte Ltd. 2021 drug formulation. [打印本頁] 作者: Malinger 時間: 2025-3-21 16:32
書目名稱Drug Discovery and Drug Development影響因子(影響力)
書目名稱Drug Discovery and Drug Development影響因子(影響力)學科排名
書目名稱Drug Discovery and Drug Development網(wǎng)絡(luò)公開度
書目名稱Drug Discovery and Drug Development網(wǎng)絡(luò)公開度學科排名
書目名稱Drug Discovery and Drug Development被引頻次
書目名稱Drug Discovery and Drug Development被引頻次學科排名
書目名稱Drug Discovery and Drug Development年度引用
書目名稱Drug Discovery and Drug Development年度引用學科排名
書目名稱Drug Discovery and Drug Development讀者反饋
書目名稱Drug Discovery and Drug Development讀者反饋學科排名
作者: OTTER 時間: 2025-3-21 21:55 作者: gratify 時間: 2025-3-22 02:35
https://doi.org/10.1007/978-3-7908-2352-3ealth care system. As per WHO recommendation, TM should be a part of health and wellness and promote safe and effective use. It can be done by proper regulation, research and integrate products, practitioners and practice into TM health systems. This can be assigned that the sum total of the knowled作者: deceive 時間: 2025-3-22 08:09
Vertical Software Industry Evolutione TB infection rates rapidly (WHO Global Tuberculosis Report 2017). The ‘standard treatment regimen’ being administered today is a combination of drugs discovered and developed in the 1950s and 1960s. This regimen falls short of an ideal therapy in many ways including the requirement of prolonged tr作者: 定點 時間: 2025-3-22 12:20 作者: 肉體 時間: 2025-3-22 13:52
https://doi.org/10.1007/978-3-7908-2367-7rogress made in efforts for new drug discovery in the country. This chapter focuses on antimalarial drug discovery and development efforts for new chemical entities, natural products, and formulations, and the current research scenario for exploring new biological targets in the parasite. It also id作者: 肉體 時間: 2025-3-22 19:41 作者: 使激動 時間: 2025-3-23 00:03
Contributions to Management Sciencey is the major cause of this disease. Enhanced blood sugar or hyperglycemia is the manifestation of this disease. If not treated timely, diabetes can damage cardiac system, blood vessels, vision, renal function and nerves leading to increased risk of cardiac disease, stroke and may cause neuronal, r作者: BILL 時間: 2025-3-23 01:27 作者: eustachian-tube 時間: 2025-3-23 06:49
,Frühfunktionelle Nachbehandlung,liv, Centhaquin, and gugulipid. Several products like CDRI-S007-867, curcuma extract, CDR-267-F018, and novel streptokinase are in pre-launch stage or Phase 1 clinical trial. Several preparations like those derived from fenugreek seeds, anti-diabetic natural product, and anti-atherosclerotic poly-he作者: anachronistic 時間: 2025-3-23 12:11 作者: 淘氣 時間: 2025-3-23 15:45
https://doi.org/10.1007/978-3-8274-2780-9s high-throughput genome sequencing and genome editing coupled with management and analysis of big data have led to the approval of novel therapeutics that have large-effect-size outcomes. These results have been reported across therapeutic areas, such as immuno-oncology, osteoporosis, rheumatoid ar作者: forestry 時間: 2025-3-23 21:42 作者: Measured 時間: 2025-3-24 01:31 作者: 鳥籠 時間: 2025-3-24 06:12
https://doi.org/10.1007/978-981-15-8002-4drug formulation; pharmacology; drug repurposing; drug delivery; pharmacokinetics; biopharmaceutics作者: 異教徒 時間: 2025-3-24 10:26
978-981-15-8004-8Springer Nature Singapore Pte Ltd. 2021作者: 倫理學 時間: 2025-3-24 11:11
Madhu DikshitDiscusses the successes and critically assesses the failures of new drug discovery efforts.Shares insights and updates on drug development in a wide range of areas such as metabolic diseases, parasiti作者: Musket 時間: 2025-3-24 16:36 作者: affluent 時間: 2025-3-24 21:21 作者: 溫室 時間: 2025-3-25 01:01 作者: 宏偉 時間: 2025-3-25 05:56 作者: esthetician 時間: 2025-3-25 07:59
,Regulatory Requirements and Quality Standards in India’s Clinical Trials Journey,e, transparent, and effective regulations for CTs to enable faster accessibility of new drug molecules in the country. The New Drugs and Clinical Trials Rules 2019 is a step in that direction. This chapter attempts to give an overview of the regulatory developments in the context of changed scenario作者: 投射 時間: 2025-3-25 12:12 作者: 不整齊 時間: 2025-3-25 18:21
rch (NDDR) journey to date. Gathering contributions from prominent researchers in the Indian Pharma Industry and Academia, this book highlights their efforts, achievements, and the status quo of Indian NDDR.??.978-981-15-8004-8978-981-15-8002-4作者: Sad570 時間: 2025-3-25 22:48
https://doi.org/10.1007/978-3-7908-2367-7vel class antibiotic mersacidin and phase 3 clinical stage/regulatory approval of Orchid’s OCID 5090, and Wockhardt’s levonadifloxacin, alalevonadifloxacin, nafithromycin, and zidebactam are discussed.作者: 和諧 時間: 2025-3-26 01:14
Network Economics in Software Marketsse in India by 2017; however, until date, target could not be achieved. This underscores the need for development of new antileishmanial agent that is administered orally. Research efforts to identify new chemical entities, using both phenotypic and target-based screening led to the identification o作者: 怎樣才咆哮 時間: 2025-3-26 05:19 作者: grieve 時間: 2025-3-26 09:52 作者: Indict 時間: 2025-3-26 15:12 作者: Priapism 時間: 2025-3-26 18:36
Traditional Medical System (TMS) for Sustainable Healthcare in India,ealth care system. As per WHO recommendation, TM should be a part of health and wellness and promote safe and effective use. It can be done by proper regulation, research and integrate products, practitioners and practice into TM health systems. This can be assigned that the sum total of the knowled作者: 憎惡 時間: 2025-3-26 23:38 作者: Duodenitis 時間: 2025-3-27 01:08 作者: Charlatan 時間: 2025-3-27 05:25
New Drug Discovery and Development in India to Counter Malaria,rogress made in efforts for new drug discovery in the country. This chapter focuses on antimalarial drug discovery and development efforts for new chemical entities, natural products, and formulations, and the current research scenario for exploring new biological targets in the parasite. It also id作者: ODIUM 時間: 2025-3-27 13:13 作者: 富饒 時間: 2025-3-27 16:43 作者: Expediency 時間: 2025-3-27 21:26
Anti-diabetes Research in India: Contributions from Industrial Organizations,n India followed by anti-diabetes drugs currently available is presented. Contributions made by various industrial R&Ds and organizations are mainly highlighted with the particular focus on organic molecules that were discovered and developed as potential anti-diabetes agents or drugs. Other agents 作者: paltry 時間: 2025-3-28 00:43 作者: OUTRE 時間: 2025-3-28 05:53 作者: Virtues 時間: 2025-3-28 09:45 作者: biopsy 時間: 2025-3-28 13:43 作者: 睨視 時間: 2025-3-28 15:10
New Drug Discovery and Development: Indian Pharmaceutical Industry,growth of Indian Pharma over the years beginning from Acharya’s foray in 1901 and traces the entry of Indian and multinational companies into manufacturing activities, the latter hedged by protective measures like MRTP ACT and Patent ACT of 1970. Sales turnovers were modest but a small number of Ind作者: 冷淡周邊 時間: 2025-3-28 20:07 作者: 離開真充足 時間: 2025-3-28 23:54
Introduction to Diabetes and Prevalence in India,damage cardiac system, blood vessels, vision, renal function and nerves leading to increased risk of cardiac disease, stroke and may cause neuronal, retinal, and kidney disease. The overall risk of morbidity and mortality among diabetes affected people is more than double compared to non-diabetic people (WHO n.d.).作者: 乳白光 時間: 2025-3-29 06:45
Indian Academia Tryst with Cardio-metabolic Drug Discovery and Development, Phase 1 clinical trial. Several preparations like those derived from fenugreek seeds, anti-diabetic natural product, and anti-atherosclerotic poly-herbal formulation are in preliminary stages. Early industry tie-ups will help the academia to accelerate the process and compete in the markets.作者: 楓樹 時間: 2025-3-29 11:16 作者: daredevil 時間: 2025-3-29 12:49
Vom Neandertal in die Philharmonieferent parts of the body is known as metastasis. Metastatic cancer is a leading cause of death among the cancer patients across the world (WHO 2018). Some other major characteristic features of cancer cells include the capability to acquire autonomous growth signals, evasion of growth inhibitory signals, angiogenesis, and unlimited replication.作者: 吼叫 時間: 2025-3-29 17:12 作者: Mortal 時間: 2025-3-29 21:45 作者: cochlea 時間: 2025-3-30 03:12
Modern Drug Discovery and Development in the Area of Cancer: Indian Context,ferent parts of the body is known as metastasis. Metastatic cancer is a leading cause of death among the cancer patients across the world (WHO 2018). Some other major characteristic features of cancer cells include the capability to acquire autonomous growth signals, evasion of growth inhibitory signals, angiogenesis, and unlimited replication.作者: Pastry 時間: 2025-3-30 07:33 作者: 外星人 時間: 2025-3-30 12:03
n a wide range of areas such as metabolic diseases, parasitiOver the years, India has attained a prominent global position in the manufacture of Generic Drugs. This success can be attributed to its synthetic organic chemistry and chemical engineering strengths, nurtured by the timely policies of the作者: Phenothiazines 時間: 2025-3-30 15:17
https://doi.org/10.1007/978-3-7908-2367-7mical entities, natural products, and formulations, and the current research scenario for exploring new biological targets in the parasite. It also identifies certain gaps and recommends future measures for strengthening research on antimalarial drugs in India.作者: MEAN 時間: 2025-3-30 16:55 作者: 農(nóng)學 時間: 2025-3-30 22:31 作者: MAPLE 時間: 2025-3-31 02:07
